Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo |
Abdou, Asmaa Gaber
(Department of Pathology, Faculty of Medicine, Menoufia University)
Maraee, Alaa (Department of Dermatology, Faculty of Medicine, Menoufia University) Yassien, Hossam (Department of Dermatology, Faculty of Medicine, Menoufia University) Sarhan, Mona (Department of Dermatology, Faculty of Medicine, Menoufia University) |
1 | Bonotis K, Pantelis K, Karaoulanis S, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges 2016; 14: 45-9. |
2 | Bhise SB, Nalawade AD, Wadhawa H. Role of protein tyrosine kinase inhibitors in cancer therapeutics. Indian J Biochem Biophys 2004; 41: 273-80. |
3 | Rane SG, Reddy EP. Janus kinases: components of multiple signaling pathways. Oncogene 2000; 19: 5662-79. DOI |
4 | Basak PY, Adiloglu AK, Koc IG, Tas T, Akkaya VB. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study. J Eur Acad Dermatol Venereol 2008; 22: 970-6. DOI |
5 | van den Boorn JG, Konijnenberg D, Dellemijn TA, et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220-32. DOI |
6 | Attwa E, Gamil H, Assaf M, Ghonemy S. Over-expression of tumor necrosis factor-alpha in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study. Arch Dermatol Res 2012; 304: 823-30. DOI |
7 | Klarquist J, Denman CJ, Hernandez C, et al. Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res 2010; 23: 276-86. DOI |
8 | Craiglow BG, King BA. Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy. JAMA Dermatol 2015; 151: 1110-2. DOI |
9 | Bhor U, Pande S. Scoring systems in dermatology. Indian J Dermatol Venereol Leprol 2006; 72: 315-21. DOI |
10 | Nada HR, El Sharkawy DA, Elmasry MF, Rashed LA, Mamdouh S. Expression of Janus kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study. Arch Dermatol Res 2018; 310: 39-46. DOI |
11 | Landry DA, Sormany F, Hache J, Roumaud P, Martin LJ. Steroidogenic genes expressions are repressed by high levels of leptin and the JAK/STAT signaling pathway in MA-10 Leydig cells. Mol Cell Biochem 2017; 433: 79-95. DOI |
12 | Bassiouny DA, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol 2011; 36: 292-7. DOI |
13 | Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8: 247-56. DOI |
14 | Alexeev V, Yoon K. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 2006; 126: 1102-10. DOI |
15 | Kortylewski M, Jove R, Yu H. Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev 2005; 24: 315-27. DOI |
16 | Nakagawa R, Yoshida H, Asakawa M, et al. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17. J Immunol 2011; 187: 4611-20. DOI |